The article ‘MiR-499 Enhances the Cisplatin Sensitivity of Esophageal Carcinoma Cell Lines by Targeting DNA Polymerase β’ [Cell Physiol Biochem 2015;36:1587-1596. DOI: 10.1159/000430321]
by Yuanyuan Wang, Jianfang Feng, Wenqiao Zang, Yuwen Du, Xiaonan Chen, Qianqian Sun, Ziming Dong and Guoqiang Zhao has been retracted by the current and former Pub- lishers and the Editor.
After publication of this article, duplication was identified between images in Figure 2D and subsequently published articles by the authors labelled as different groups [1,2]. When asked to comment the corresponding author stated that there was no error in the Figures in this article. The journal determined that this response was unsatisfactory. The matter was, therefore, raised to the corresponding author’s institution which did not respond to our request for an investigation. Given the severity of the concerns raised this article is being retracted.
The authors did not respond to correspondence about this retraction within the time- frame specified or could not be reached.
| 1 | Wang Y, Sun Q, Guo W, Chen X, Du Y, Zang W, Dong Z, Zhao G. G648C variant of DNA polymerase β sensitizes esophageal cancer to chemotherapy. Tumor Biology. 2016 Feb;37:1941-7. |
| 2 | WuS,ZhangG,LiP,ChenS,ZhangF,LiJ,JiangC,ChenX,WangY,DuY,SunQ. RETRACTED ARTICLE: miR-198 targets SHMT1 to inhibit cell proliferation and enhance cell apoptosis in lung adenocarcinoma. Tumor Biology. 2016 Apr;37:5193-202. |